Publication | Closed Access

Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor

InflammationRheumatologyRheumatoid DisorderAnti-inflammatoryAutoimmune DiseaseNovel Syk InhibitorMedicineImmunologyPharmacologyOsteoarthritisInflammatory Rheumatic DiseaseBone ErosionPsoriatic ArthritisOsteoporosisRheumatoid Arthritis